cgp 42112a has been researched along with 1-methyl-4-phenylpyridinium in 1 studies
Studies (cgp 42112a) | Trials (cgp 42112a) | Recent Studies (post-2010) (cgp 42112a) | Studies (1-methyl-4-phenylpyridinium) | Trials (1-methyl-4-phenylpyridinium) | Recent Studies (post-2010) (1-methyl-4-phenylpyridinium) |
---|---|---|---|---|---|
233 | 0 | 35 | 1,854 | 1 | 593 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiueh, CC; de Oliveira, AM; Saavedra, JM; Viswanathan, M; Wu, RM | 1 |
1 other study(ies) available for cgp 42112a and 1-methyl-4-phenylpyridinium
Article | Year |
---|---|
[125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP+)-induced brain injury.
Topics: 1-Methyl-4-phenylpyridinium; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Binding Sites; Biphenyl Compounds; Brain; Brain Injuries; Imidazoles; Iodine Radioisotopes; Losartan; Male; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Substantia Nigra; Tetrazoles | 1994 |